Amoy Diagnostics Co., Ltd. (SHE:300685)
China · Delayed Price · Currency is CNY 19.57
-0.73 (-3.60%)
Oct 12, 2026, 3:04 PM CST
Amoy Diagnostics Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 7,467 | 7,915 | 8,978 | 8,675 | 10,531 | 16,742 | |
Market Cap Growth | -16.08% | -11.84% | 3.50% | -17.63% | -37.10% | -3.54% |
Enterprise Value | 6,438 | 6,702 | 7,948 | 7,849 | 9,856 | 16,089 |
Last Close Price | 20.30 | 20.00 | 21.97 | 21.00 | 25.14 | 39.68 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 24.13 | 21.91 | 35.23 | 33.17 | 39.93 | 69.88 |
Forward PE | 20.71 | 23.52 | 26.07 | 32.48 | 48.14 | 66.37 |
PS Ratio | 6.58 | 6.61 | 8.10 | 8.31 | 12.51 | 18.26 |
PB Ratio | 4.09 | 3.85 | 4.87 | 5.09 | 7.02 | 12.22 |
P/TBV Ratio | 4.17 | 3.93 | 4.99 | 5.24 | 7.25 | 12.44 |
P/FCF Ratio | 23.58 | 26.87 | 29.76 | 34.17 | 148.85 | 178.84 |
P/OCF Ratio | 19.91 | 21.70 | 26.26 | 29.04 | 70.66 | 99.56 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 5.70 | 5.60 | 7.17 | 7.52 | 11.70 | 17.54 |
EV/EBITDA Ratio | 15.35 | 15.59 | 24.14 | 24.36 | 51.48 | 59.26 |
EV/EBIT Ratio | 17.04 | 17.38 | 28.67 | 29.13 | 68.61 | 68.45 |
EV/FCF Ratio | 20.45 | 22.75 | 26.35 | 30.92 | 139.30 | 171.86 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.10 | 0.05 | 0.03 | 0.03 | 0.04 | 0.00 |
Debt / EBITDA Ratio | 0.45 | 0.25 | 0.17 | 0.17 | 0.27 | 0.02 |
Debt / FCF Ratio | 0.60 | 0.37 | 0.19 | 0.22 | 0.76 | 0.07 |
Net Debt / Equity Ratio | -0.54 | -0.60 | -0.61 | -0.57 | -0.47 | -0.52 |
Net Debt / EBITDA Ratio | -2.38 | -2.87 | -3.41 | -2.99 | -3.66 | -2.62 |
Net Debt / FCF Ratio | -3.13 | -4.19 | -3.72 | -3.80 | -9.90 | -7.61 |
Asset Turnover | 0.53 | 0.54 | 0.56 | 0.58 | 0.53 | 0.65 |
Inventory Turnover | 4.90 | 6.11 | 5.74 | 5.74 | 4.71 | 5.48 |
Quick Ratio | 14.94 | 11.26 | 8.91 | 9.06 | 13.48 | 8.54 |
Current Ratio | 15.42 | 11.53 | 9.18 | 9.29 | 13.97 | 8.85 |
Return on Equity (ROE) | 17.90% | 18.53% | 14.37% | 16.33% | 18.42% | 19.14% |
Return on Assets (ROA) | 11.18% | 10.93% | 8.67% | 9.39% | 5.66% | 10.45% |
Return on Invested Capital (ROIC) | 41.73% | 43.96% | 33.44% | 31.09% | 18.22% | 39.85% |
Return on Capital Employed (ROCE) | 18.90% | 17.80% | 14.80% | 15.30% | 9.20% | 17.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 4.37% | 4.56% | 2.84% | 3.01% | 2.50% | 1.43% |
FCF Yield | 4.24% | 3.72% | 3.36% | 2.93% | 0.67% | 0.56% |
Dividend Yield | 2.30% | 2.25% | 1.37% | 0.71% | 0.56% | 0.32% |
Payout Ratio | 60.17% | 32.93% | 23.77% | 21.48% | 19.52% | 23.14% |
Buyback Yield / Dilution | -1.75% | -0.80% | -0.51% | -0.65% | 1.41% | 0.36% |
Total Shareholder Return | 0.55% | 1.45% | 0.85% | 0.07% | 1.97% | 0.68% |